Table 5 |
|||||
|
Treatment of erectile dysfunction |
|||||
|
Erectile dysfunction severity |
|||||
|
|
|||||
|
Mild (n = 25) |
Mild to moderate (n = 26) |
Moderate (n = 14) |
Severe (n = 40) |
All (n = 105) |
|
|
|
|||||
|
Sildenafil |
20 |
8 |
31 |
11 |
15 |
|
Tadalafil |
12 |
8 |
15 |
11 |
11 |
|
Vardenafil |
0 |
4 |
0 |
0 |
1 |
|
Alprostadil urethral |
0 |
0 |
0 |
0 |
0 |
|
Alprostadil cavernous |
0 |
0 |
15 |
0 |
2 |
|
Vacuum device |
0 |
0 |
0 |
0 |
0 |
|
Penile prosthesis |
0 |
0 |
0 |
5 |
2 |
|
|
|||||
|
Data represent percent of men on each treatment modality. A total of 3 men received combination therapy. |
|||||
|
Foocharoen et al. Arthritis Research & Therapy 2012 14:R37 doi:10.1186/ar3748 |
|||||
